<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01321021</url>
  </required_header>
  <id_info>
    <org_study_id>2011DR2032</org_study_id>
    <nct_id>NCT01321021</nct_id>
  </id_info>
  <brief_title>Influence of Losartan and Diphenhydramine on Emotional and Cognitive Functions in Healthy Human Subjects</brief_title>
  <acronym>LoDi-Basel</acronym>
  <official_title>Influence of Losartan and Diphenhydramine on Emotional and Cognitive Functions in Healthy Human Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Prof. Dominique de Quervain, MD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Clinical Trial Unit, University Hospital Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Basel</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project aims at identifying novel pharmacological targets for the treatment of memory
      disorders.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To investigate the effects of the histamine H1 receptor antagonist diphenhydramine and the
      angiotensin II receptor antagonist losartan on emotional and cognitive functions in healthy
      human subjects.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2011</start_date>
  <completion_date type="Actual">August 2011</completion_date>
  <primary_completion_date type="Actual">July 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary Outcome Measures</measure>
    <time_frame>during cognitive testing at study days</time_frame>
    <description>Memory functions</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Secondary Outcome Measures</measure>
    <time_frame>during cognitive testing at study days</time_frame>
    <description>sleepiness, mood, anxiety, attention, fluid intelligence</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Memory, Long-Term</condition>
  <condition>Memory, Short-Term</condition>
  <arm_group>
    <arm_group_label>Losartan, Diphenhydramine, Placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>placebo controlled crossover study with two arms: Losartan, Diphenhydramine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Losartan, Diphenhydramine, Placebo</intervention_name>
    <description>placebo controlled crossover study with two arms: Losartan 40mg, Diphenhydramine 40mg</description>
    <arm_group_label>Losartan, Diphenhydramine, Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy

          -  native or fluent German-speaking

          -  BMI between 19 and 27 kg/m2

          -  able and willing to give written informed consent and comply with the requirements of
             the study protocol

          -  willing to donate saliva sample for DNA-analysis

          -  female: willing to perform a pregnancy test at the beginning of both test visits

        Exclusion Criteria:

          -  acute or chronic psychiatric or somatic disorder

          -  pathological ECG

          -  known hypersensitivity to the IMP under investigation (losartan, diphenhydramine)

          -  hypotension (RR &lt; 110/70 mmHg)

          -  bradycardia (&lt; 50 bpm)

          -  pregnancy, breast-feeding

          -  long-term medication within last 3 months (oral contraceptives are disregarded)

          -  smoking (&gt; 3 cigarettes per day)

          -  concurrent participation in another study

          -  participation in one of our previous studies using the same memory tests

          -  inability to read and understand the participant's information
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dominique de Quervain, Prof. MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Basel, Faculty of Psychology and Medecine, Division of Cognitive Neuroscience</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Basel, Division of Cognitive Neuroscience</name>
      <address>
        <city>Basel</city>
        <zip>4055</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>May 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 22, 2011</study_first_submitted>
  <study_first_submitted_qc>March 22, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 23, 2011</study_first_posted>
  <last_update_submitted>May 2, 2012</last_update_submitted>
  <last_update_submitted_qc>May 2, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 3, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Basel</investigator_affiliation>
    <investigator_full_name>Prof. Dominique de Quervain, MD</investigator_full_name>
    <investigator_title>Prof., MD</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Losartan</mesh_term>
    <mesh_term>Diphenhydramine</mesh_term>
    <mesh_term>Promethazine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

